Koffiekamer « Terug naar discussie overzicht

3D printing

6.220 Posts, Pagina: « 1 2 3 4 5 6 ... 124 125 126 127 128 129 130 131 132 133 134 ... 307 308 309 310 311 » | Laatste
nobahamas
0
Arcam:
Ik heb de verkoop van het aantal systemen in een grafiek geplaatst voor de beeldvorming.
(Q20 systemen zijn al opgenomen in de aantallen.)
Bijlage:
mjmj
0
je kan je afvragen waarom ze zoveel orders in december hebben laten vallen voor zover deze 'planbaar' zijn natuurlijk. En ik neem aan dat ze wel enige speelruimte hebben in hun keuze om orders eind december te melden of begin januari.
nobahamas
0
quote:

nobahamas schreef op 24 december 2014 17:55:

Arcam:
Ik heb de verkoop van het aantal systemen in een grafiek geplaatst voor de beeldvorming.
(Q20 systemen zijn al opgenomen in de aantallen.)
Hier de jaarverkopen er ook bij
Bijlage:
mjmj
0
nobahamas
0
Blij dat jij er nog bent.
Ik ben erg benieuwd wat januari wordt. Nog zon maand en de koers kan verdubbelen
hirshi
0
Noba,

Het blijft een interessante sector.

Maar constateren van koersbewegingen van een witte raaf is gemakkelijker dan daarop vooruitlopen.

Hopelijk ga je in 2015 door met beschouwingen want je bent als kenner altijd het lezen van je berichten waard.

Het wachten is op de omslag en die gaat een keer komen.

Groet.

nobahamas
0
Dank Hirsh, een boeiende sector is het zeker, veel potentie maar nog dik in de rode cijfers.
Maar ik denk toch wel binnen enkele maanden één of twee bedrijven te kunnen benoemen die de komende jaren werkelijk geld gaan verdienen.
hirshi
0
Graag noba want je hebt je credits wel verdiend intussen.

Mensen met kennis van zaken hebben altijd een voorsprong.

Groet en een succesvol 2015 toegewenst.
nobahamas
0
Toch wel even het melden waard:
Xone plus 17,3%
DDD plus 7,9%
SSYS plus 3,4%
MTLS plus 4,6%
AMAVF plus 1,7%

Ik voorzie een aanmerkelijke afname in shortposities in de markt.
nobahamas
0
Heet van de pers:
Arcam, listed on NASDAQ Stockholm, today received two separate orders for EBM systems for clients in Italy and in China.

"With these two orders we close 2014 with a total order intake of 42 EBM systems, an increase of about 55% compared to the order intake in 2013. The increase in order intake confirms the strong interest in our EBM systems for additive manufacturing and lays a solid foundation for continued growth in 2015 and onwards”, says Magnus René, CEO of Arcam.
nobahamas
0
mjmj
0
Volgens mijn ovz: 42 systemen.
Het blijft vreemd dat ze op de valreep van 2014 nog 2 orders melden.... waarom niet in het nieuwe jaar? Ook die uitspraak van de CEO op de laatste dag, waarom deze timing? Media exposure is minimaal vandaag.

Koers reageert niet of nauwelijks.

Het zou leuk zijn als je weer een bijgewerkt staafdiagrammetje kunt posten.
Verder: een succesvol 3D beleggingsjaar toegewenst.

Bijgewerkt overzicht t/m 31 december.

Order intake en leveringen bij arcam:

2012: 24 (orders), 15 (geleverd)
2013: 27 (orders), 25 (geleverd)
2014 t/m Q3: 21 (orders), 20 (geleverd)
Meldingen van orders:
oct 6
oct 14
oct 16
oct 24
nov 11
nov 25
nov 26
dec 2
dec 2
dec 4 (5 orders)
dec 4
dec 15 (2 Q10's)
dec 22 (Q10?)
dec 23 Q20
dec 31 2 orders

Per 31 december zitten we dus op: 42 systemen (orders) voor 2014
mjmj
0
Ik neig ernaar om te denken dat de mededeling van de CEO is bedoeld om de koers op de laatste dag van het jaar omhoog te praten. Als dat zo is dan maakt hij zich kennelijk zorgen over de koersontwikkeling.

Zie voor grafiek:
finance.yahoo.com/echarts?s=ARCM.ST+I...
nobahamas
0

Overgenomen van een Zweeds forum:

www.redeye.se/aktiebloggen/arcam/arca...

Vertaald door Google:

Arcam has never been stronger than it is now. In combination with the valuation starts to look 'normal' out, I think it is time to buy. The potential for the company's 3D technology is no less just because the stock has been halved.

Introduction

2013 was the year when the financial world seriously discovered 3D printing. Large items from several of the world's most respected magazines and fat analysis from Wall Street's big financial houses pointed out Additive Manufacturing (AM) as one of the most important future technologies. Investors who wanted to gain exposure to PM, however, had only a handful of companies to choose from including Swedish Arcam was one of them. The huge demand for AM shares in combination with an extremely scant supply drove up the values ??to a rather absurd levels. Arcam's value on the top 5.5 billion, with a turnover of SEK 200 million, ie 28 times sales! As so often when shares rise parabolic gets the rebound merciless and prolonged when it finally arrives. Of the American companies are Statasys who have fallen at least from the top, -40%. 3D Systems, Exone and Voxeljet is all down by 60-90%. Arcam has lost over 50% of its ancient great value.

I see clear parallels to the IT bubble around the turn of the millennium, where many IT companies disappeared in the ensuing crash, but also leading companies such as Amazon.com fell sharply (down 95% from the peak just above 100 dollars to the bottom around $ 6 two years later). Today, 15 years later Amazon will cost just over $ 300 and peaked just above $ 400 in early 2014. So even if one dotted peak of the dotcom bubble so did it 4 times the money to retain the shares for 15 years. Similarly, I believe that the winners of the AM sector will bring new much higher peaks in the future and Arcam has good chances to be one of them. The question for me is urgently where and when in this large correction to buy shares?

Consulting firm Gartner has prepared a "Hype Cycle" describing five typical phases that new technologies often undergo;

en.m.wikipedia.org/wiki/Hype_cycle

I would argue that we are now in Phase 3 - "Trough of Disillusionment" or loosely translated "disappointment valley". The initial hype is long gone and the growth of AM is lower than hoped for at the peak of the hype. However, it is my belief that the future of AM is very light, especially in the segment Arcam compete, industrial printers. If my assumption is correct, it is a matter of time before we go into phase 4 where the method's usefulness in several areas is becoming increasingly apparent. Soon enough follow Phase 5 where mass deployment occurs, but there are probably a few years away I guess.

The technique

Additive manufacturing is a manufacturing method in which the manufactured built up layer by layer by a CAD drawing. There are several benefits over traditional manufacturing techniques such as casting, turning, punching, etc;

- The products will be easier because "the air is being built in". Particularly interesting for the aerospace industry because every kilo on fuel costs.

- Complex parts can be manufactured in one step, rather than in separate parts. In some cases enables AM a complexity that is impossible with other methods.

- Less waste, since virtually all the raw material can be utilized. Especially important for products produced by more expensive materials such as titanium.

- New product features. Within medtech one is mainly interested in the products where human bones and tissue can grow into the printed part.

- Parts can be manufactured "on-site" that is, in the customer's plant instead of the customer to sit on a large team of components. Reduces capital accumulation and needs for supplies. Clients are also plenty of tools that also binds capital and need to be replaced and updated.

- Parts can be customized. Particularly interesting for medtech as standardized parts may not fit the specific patient.

One drawback is that today's printers are significantly slower than traditional methods. Technology evolves, however, and in 2015 is expected Arcam launch a new generation printers by 2-3 times higher power and at least twice as high print speed. At this stage, AM only compete in smaller production runs or where the characteristics outweigh the time spent. It is therefore logical that Arcam has chosen to focus on the aviation industry and the implant industry so far. The CEO, however, mentioned that you look at more segments, including the automotive industry.

Business Model

Arcam printers cost between 4 and 7 million each (hereinafter referred to as ASP, average sales price). The system Q10 is designed for implant industry and located in the lower end of the price range. Q20 is designed for the aerospace industry and is located in the upper part. In addition to this non-recurring income selling Arcam metal powder, service and spare parts with a value of approximately SEK 800,000 per machine per year. The business model is thus an element of razor-blade where the Arcam like Gillette assuming a stable recurring revenue stream from the installed base of machines. To take a stronger control over the powder supply bought Arcam AP & C, a leading powder manufacturers in 2014.

6.220 Posts, Pagina: « 1 2 3 4 5 6 ... 124 125 126 127 128 129 130 131 132 133 134 ... 307 308 309 310 311 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

 AEX
921,92  -3,99  -0,43%  28 feb
 Germany40^ 22.555,90 +0,02%
 BEL 20 4.420,51 -0,60%
 Europe50^ 5.455,27 -0,15%
 US30^ 43.818,00 0,00%
 Nasd100^ 20.879,40 0,00%
 US500^ 5.952,17 0,00%
 Japan225^ 37.585,40 0,00%
 Gold spot 2.857,60 0,00%
 EUR/USD 1,0375 -0,20%
 WTI 70,08 0,00%
#/^ Index indications calculated real time, zie disclaimer

Stijgers

Van Lanschot ... +4,09%
ADYEN NV +2,53%
HEIJMANS KON +1,76%
ACOMO +1,59%
DSM FIRMENICH AG +1,48%

Dalers

Kendrion -5,98%
AMG Critical ... -4,99%
AZERION -4,20%
AALBERTS NV -3,13%
ASML -2,93%